Inhibition of ENT1 Relieves Intracellular Adenosine-Mediated T Cell Suppression in Cancer

Researchers showed that adenosine suppresses anti-cancer T cell responses following uptake into activated T cells by equilibrative nucleoside transporter 1 (ENT1) and inhibition of de novo pyrimidine nucleotide synthesis.